You are here:

Forthcoming Submissions:

PACE medicines

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due
pegvisomant (Somavert) Pfizer Ltd Resubmission 31/07/2017 Q3 2017 Q4 2017

Non-PACE medicines

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due
desmopressin oral lyophilisate (Noqdirna) Ferring Pharmaceuticals Ltd Resubmission 5/06/2017 4/07/2017 7/08/2017
saxagliptin - dapagliflozin (Qtern) AstraZeneca UK Ltd Abbreviated Submission N/A 6/06/2017 10/07/2017

Medicines with advice withheld pending product availability

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due
empaglifozin linagliptin fixed-dose combination (Glyxambi) Boehringer Ingelheim Ltd Abbreviated Submission N/A 4/04/2017 TBC

Back